Hans-Peter Tony Selected Research

Hans-Peter Tony Research Topics

Disease

45	Rheumatoid Arthritis 09/2022 - 01/2005
10	Infections 11/2021 - 02/2009
6	Systemic Scleroderma (Systemic Sclerosis) 01/2021 - 06/2014
4	Pain (Aches) 09/2022 - 11/2016
4	Rheumatic Diseases (Rheumatism) 11/2021 - 06/2008
3	Psoriatic Arthritis 06/2022 - 03/2016
3	Inflammation (Inflammations) 08/2021 - 09/2016
3	Vasculitis (Vasculitides) 01/2018 - 05/2011
3	Necrosis 09/2017 - 06/2007
3	Autoimmune Diseases (Autoimmune Disease) 05/2011 - 03/2003
3	Lymphoma (Lymphomas) 04/2004 - 07/2003
2	Fatigue 09/2022 - 11/2016
2	Giant Cell Arteritis (Horton Disease) 08/2021 - 01/2018
2	Diffuse Scleroderma (Progressive Systemic Sclerosis) 10/2019 - 06/2014
2	Sepsis (Septicemia) 01/2018 - 06/2007
2	Non-Hodgkin Lymphoma (Lymphosarcoma) 05/2011 - 07/2003
2	Systemic Lupus Erythematosus (Libman-Sacks Disease) 05/2011 - 05/2010
1	Sleep Initiation and Maintenance Disorders (Insomnia) 09/2022
1	Renal Insufficiency (Renal Failure) 09/2022
1	Coronary Disease (Coronary Heart Disease) 09/2022
1	Back Pain (Backache) 10/2021
1	Axial Spondyloarthritis 10/2021
1	Pulmonary Arterial Hypertension 01/2021
1	Encephalitis (Encephalitis, Rasmussen) 01/2020
1	Autoimmune Diseases of the Nervous System 01/2020
1	Common Variable Immunodeficiency 01/2020
1	Herpes Zoster 11/2019
1	Hypersensitivity (Allergy) 01/2019
1	Anaphylaxis (Anaphylactic Shock) 01/2019
1	Crohn Disease (Crohn's Disease) 12/2018
1	Psoriasis (Pustulosis Palmaris et Plantaris) 12/2018
1	T-Cell Lymphoma (Lymphoma, T Cell) 12/2018
1	Persistent Infection 11/2018
1	Chronic Hepatitis C 01/2018
1	Liver Diseases (Liver Disease) 01/2018
1	Takayasu Arteritis (Arteritis, Takayasu's) 01/2018
1	Bites and Stings (Sting) 01/2017
1	Precursor Cell Lymphoblastic Leukemia-Lymphoma (Acute Lymphoblastic Leukemia) 01/2017
1	Synovitis 12/2016
1	Arthritis (Polyarthritis) 04/2016
1	Graft vs Host Disease (Graft-Versus-Host Disease) 12/2015
1	Dry Eye Syndromes (Dry Eye Syndrome) 12/2014

Drug/Important Bio-Agent (IBA)

20	Rituximab (Mabthera)FDA Link 11/2021 - 01/2005
9	Adalimumab (Humira)FDA Link 09/2020 - 09/2012
8	tocilizumab (atlizumab)FDA Link 09/2022 - 05/2011
7	CytokinesIBA 01/2021 - 07/2003
7	Antirheumatic Agents (DMARD)IBA 11/2019 - 01/2014
7	AntibodiesIBA 01/2019 - 03/2003
7	AutoantibodiesIBA 01/2019 - 03/2003
6	Biological ProductsIBA 05/2020 - 06/2012
4	Janus Kinase InhibitorsIBA 01/2022 - 04/2015
3	Interferon-gamma (Interferon, gamma)IBA 08/2021 - 07/2003
3	Biosimilar PharmaceuticalsIBA 01/2021 - 09/2017
3	Interleukin-6 (Interleukin 6)IBA 04/2016 - 05/2011
2	ametantrone (HAQ)IBA 09/2022 - 01/2019
2	tofacitinibIBA 11/2019 - 04/2015
2	3-benzoyl dopamine (MBDA)IBA 01/2019 - 09/2016
2	baricitinibIBA 01/2019 - 01/2018
2	Proteins (Proteins, Gene)FDA Link 01/2019 - 02/2017
2	Tumor Necrosis Factor InhibitorsIBA 12/2018 - 02/2009
2	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 12/2018 - 02/2009
2	Prednisolone (Predate)FDA LinkGeneric 01/2018 - 06/2007
2	Methotrexate (Mexate)FDA LinkGeneric 09/2017 - 03/2016
2	Immunoglobulin G (IgG)IBA 04/2016 - 11/2005
2	Cyclophosphamide (Cytoxan)FDA LinkGeneric 06/2014 - 06/2007
2	Antineutrophil Cytoplasmic Antibodies (ANCA)IBA 11/2012 - 05/2011
2	DNA (Deoxyribonucleic Acid)IBA 05/2010 - 06/2007
2	AntigensIBA 05/2010 - 06/2007
2	nuclear pore protein p62IBA 05/2010 - 03/2003
2	SiliconesIBA 04/2004 - 09/2003
1	GlucocorticoidsIBA 09/2022
1	Interleukin-17 (Interleukin 17)IBA 06/2022
1	ixekizumabIBA 06/2022
1	sarilumabIBA 01/2022
1	Glucose (Dextrose)FDA LinkGeneric 11/2021
1	Leflunomide (Arava)FDA LinkGeneric 11/2021
1	Contrast MediaIBA 08/2021
1	InterleukinsIBA 08/2021
1	secukinumabIBA 08/2021
1	Interleukin-9 (Interleukin 9)IBA 01/2021
1	Prostaglandins AIBA 05/2020
1	Hepatitis B Surface Antigens (HBsAg)FDA Link 11/2018
1	SteroidsIBA 01/2018
1	Bile Acids and Salts (Bile Acids)IBA 01/2018
1	Antiviral Agents (Antivirals)IBA 01/2018
1	blinatumomabIBA 01/2017
1	CD19 AntigensIBA 01/2017
1	Anti-Citrullinated Protein AntibodiesIBA 12/2016
1	Antilymphocyte Serum (Anti-Thymocyte Globulin)IBA 12/2015
1	Interleukin-6 Receptors (Interleukin 6 Receptor)IBA 03/2015
1	Fluorescein (Funduscein)FDA LinkGeneric 12/2014

Therapy/Procedure

21	Therapeutics 10/2021 - 07/2003
7	Hematopoietic Stem Cell Transplantation 01/2021 - 06/2014
3	Aftercare (After-Treatment) 08/2021 - 06/2014
2	Immunotherapy 01/2017 - 07/2003
1	Transplantation 01/2021
1	Stem Cell Transplantation 01/2020
1	Salvage Therapy 01/2018
1	Vascular Surgical Procedures 01/2018
1	Biological Therapy 05/2015